ATE192046T1 - Mycobacterium vaccae zur behandlung von lang andauernden autoimmunerkrankungen - Google Patents

Mycobacterium vaccae zur behandlung von lang andauernden autoimmunerkrankungen

Info

Publication number
ATE192046T1
ATE192046T1 AT96201912T AT96201912T ATE192046T1 AT E192046 T1 ATE192046 T1 AT E192046T1 AT 96201912 T AT96201912 T AT 96201912T AT 96201912 T AT96201912 T AT 96201912T AT E192046 T1 ATE192046 T1 AT E192046T1
Authority
AT
Austria
Prior art keywords
treatment
long
autoimmune diseases
mycobacterium vaccae
lasting
Prior art date
Application number
AT96201912T
Other languages
English (en)
Inventor
John Lawson Stanford
Graham Arthur William Rook
Original Assignee
Stanford Rook Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanford Rook Ltd filed Critical Stanford Rook Ltd
Application granted granted Critical
Publication of ATE192046T1 publication Critical patent/ATE192046T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • External Artificial Organs (AREA)
  • Soil Working Implements (AREA)
  • Storage Of Fruits Or Vegetables (AREA)
AT96201912T 1992-02-21 1993-02-19 Mycobacterium vaccae zur behandlung von lang andauernden autoimmunerkrankungen ATE192046T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929203814A GB9203814D0 (en) 1992-02-21 1992-02-21 Treatment of long term auto-immune conditions

Publications (1)

Publication Number Publication Date
ATE192046T1 true ATE192046T1 (de) 2000-05-15

Family

ID=10710862

Family Applications (2)

Application Number Title Priority Date Filing Date
AT96201912T ATE192046T1 (de) 1992-02-21 1993-02-19 Mycobacterium vaccae zur behandlung von lang andauernden autoimmunerkrankungen
AT93905460T ATE151641T1 (de) 1992-02-21 1993-02-19 Mycobacterium vaccae zur behandlung von langwierigen autoimmunerkrankungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT93905460T ATE151641T1 (de) 1992-02-21 1993-02-19 Mycobacterium vaccae zur behandlung von langwierigen autoimmunerkrankungen

Country Status (24)

Country Link
US (1) US5885588A (de)
EP (2) EP0630259B1 (de)
JP (1) JPH07506093A (de)
KR (1) KR100275862B1 (de)
AT (2) ATE192046T1 (de)
AU (2) AU675421B2 (de)
BG (1) BG99054A (de)
BR (1) BR9305946A (de)
CA (1) CA2130117A1 (de)
CZ (1) CZ282651B6 (de)
DE (2) DE69309915T2 (de)
DK (2) DK0763361T3 (de)
ES (2) ES2104131T3 (de)
FI (1) FI943849A0 (de)
GB (1) GB9203814D0 (de)
GR (2) GR3024113T3 (de)
HU (1) HU218347B (de)
NO (1) NO311169B1 (de)
NZ (1) NZ249518A (de)
RO (1) RO117833B1 (de)
RU (1) RU2124367C1 (de)
SK (1) SK99994A3 (de)
UA (1) UA35583C2 (de)
WO (1) WO1993016727A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9406301D0 (en) * 1994-03-30 1994-05-25 Univ London Immunotherapeutic agent and its use
IL110011A (en) * 1994-06-13 2004-09-27 Yeda Res & Dev Pharmacological preparations for the treatment of schizophrenia
GB9505658D0 (en) * 1995-03-21 1995-05-10 Univ London Hormone and growth factor mimetics
US6056964A (en) * 1995-03-29 2000-05-02 Stanford Rook Limited Immunotherapeutic agent and its use
US6160093A (en) * 1996-08-29 2000-12-12 Genesis Researth And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
AU741016B2 (en) * 1996-08-29 2001-11-22 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6878377B2 (en) 1996-12-18 2005-04-12 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system
JP4358306B2 (ja) * 1996-12-18 2009-11-04 スタンフォード ルーク リミティド 免疫系のＴｈ２活性のダウン−レギュレーションのためのマイコバクテリア・ワクチン
RU2137137C1 (ru) * 1997-12-03 1999-09-10 Научно-исследовательский институт по изучению лепры Способ определения m.leprae у больных с регрессом заболевания
CA2315539A1 (en) * 1997-12-23 1999-07-01 Genesis Research & Development Corporation Limited Compositions derived from mycobacterium vaccae and methods for their use
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
AU6896300A (en) * 1999-08-06 2001-03-05 Corixa Corporation Vaccines for the treatment of autoimmune disease
GB0010496D0 (en) * 2000-04-28 2000-06-14 Stanford Rook Ltd Treatment of conditions of the central nervous system
GB0106985D0 (en) * 2001-03-20 2001-05-09 Stanford Rook Ltd Immunotherapeutic agent
GB0106986D0 (en) * 2001-03-20 2001-05-09 Stanford Rook Ltd Immunotherapeutic agent
AR046583A1 (es) 2003-11-14 2005-12-14 Ucl Biomedica Plc Uso de una composicion inmunomoduladora

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8404280D0 (en) * 1984-02-17 1984-03-21 Stanford J L Biological preparations
IL71683A0 (en) * 1984-04-27 1984-09-30 Yeda Res & Dev Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
ATE154759T1 (de) * 1990-11-08 1997-07-15 Univ London Mycobacterium als adjuvans für antigene

Also Published As

Publication number Publication date
HUT69941A (en) 1995-09-28
SK99994A3 (en) 1995-05-10
GR3033772T3 (en) 2000-10-31
GB9203814D0 (en) 1992-04-08
AU706122B2 (en) 1999-06-10
DE69328503D1 (de) 2000-05-31
DK0630259T3 (da) 1997-09-15
EP0630259B1 (de) 1997-04-16
NZ249518A (en) 1997-07-27
CZ202394A3 (en) 1995-02-15
RU94045825A (ru) 1997-02-20
NO943082D0 (no) 1994-08-22
EP0763361A2 (de) 1997-03-19
KR100275862B1 (ko) 2000-12-15
NO943082L (no) 1994-10-17
AU675421B2 (en) 1997-02-06
CA2130117A1 (en) 1993-09-02
ES2145968T3 (es) 2000-07-16
KR950700755A (ko) 1995-02-20
DE69309915D1 (de) 1997-05-22
UA35583C2 (uk) 2001-04-16
EP0763361B1 (de) 2000-04-26
ES2104131T3 (es) 1997-10-01
BR9305946A (pt) 1997-10-21
AU7188796A (en) 1997-02-06
NO311169B1 (no) 2001-10-22
DK0763361T3 (da) 2000-08-07
DE69309915T2 (de) 1997-07-24
ATE151641T1 (de) 1997-05-15
RO117833B1 (ro) 2002-08-30
RU2124367C1 (ru) 1999-01-10
HU9402422D0 (en) 1994-10-28
FI943849A0 (fi) 1994-08-22
DE69328503T2 (de) 2000-08-24
BG99054A (en) 1995-08-28
AU3637793A (en) 1993-09-13
EP0630259A1 (de) 1994-12-28
EP0763361A3 (de) 1997-03-26
JPH07506093A (ja) 1995-07-06
HU218347B (hu) 2000-08-28
CZ282651B6 (cs) 1997-08-13
GR3024113T3 (en) 1997-10-31
WO1993016727A1 (en) 1993-09-02
US5885588A (en) 1999-03-23

Similar Documents

Publication Publication Date Title
ATE192046T1 (de) Mycobacterium vaccae zur behandlung von lang andauernden autoimmunerkrankungen
GB9024320D0 (en) Treatment of uveitis
DE3752364D1 (de) Osteoinduktive Zusammensetzungen
DE69202019D1 (de) Verwendung von essentiellen Fettsäuren zur Herstellung eines Arzneimittels zur Behandlung von AIDS.
DE69128932D1 (de) Verfahren zur Herstellung von Epsilon-caprolactam und Aktivierung von festen Katalysatoren dafür
DE69017418D1 (de) Verfahren zur Herstellung von gepfropften Polyolen und daraus erhaltene Polyolen.
RU93004600A (ru) Применение mycobacterium vaccae, способ лечения, продукт m vaccae, иммунотерапевтический агент
FI920356A0 (fi) En biologisk preparation samt dess anvaendning.
ATE148628T1 (de) 5-methylisoxazol-4-carbonsäure-anilide und 2- hydroxyethyliden-cyanoessigsäure-anilide zur behandlung von augenkrankheiten
EP0303681A4 (de) Immunosuppression bei der auf immunotoxin basierten behandlung von menschen.
DE69305267D1 (de) Zusammensetzung zur Behandlung von Mastitis und Metritis
EP0674905A3 (de) Bacterin zur Behandlung von Necrophorum-Krankheiten und Verfahren zur Herstellung.
FI901371A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten halogeeni-3,4-dihydro-bentsotiopyranyyliamiinien valmistamiseksi
ATE315583T1 (de) Analoge des thymosin alpha 1
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.
ATE56874T1 (de) Zubereitung zur behandlung und vorbeugung von diarrhoee bei menschen und tieren und verfahren zu deren herstellung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee